IRIS
SVEGLIATI BARONI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.135
EU - Europa 1.822
AS - Asia 654
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 5.662
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.128
UA - Ucraina 422
IT - Italia 280
SE - Svezia 278
IE - Irlanda 238
DE - Germania 202
TR - Turchia 199
SG - Singapore 192
CN - Cina 164
DK - Danimarca 155
FI - Finlandia 86
KR - Corea 85
FR - Francia 84
GB - Regno Unito 53
CI - Costa d'Avorio 24
BE - Belgio 16
MA - Marocco 16
IN - India 10
CA - Canada 7
EU - Europa 6
AU - Australia 3
RS - Serbia 3
EG - Egitto 2
JP - Giappone 2
RU - Federazione Russa 2
ES - Italia 1
NL - Olanda 1
PK - Pakistan 1
RO - Romania 1
VN - Vietnam 1
Totale 5.662
Salva come PNG Salva come JPEG
Città #
Chandler 604
Jacksonville 434
Boardman 242
Dublin 235
Fairfield 183
Ashburn 149
Wilmington 136
New York 119
Lawrence 93
Princeton 93
Singapore 90
Centro 87
San Mateo 87
Woodbridge 86
Des Moines 80
Ann Arbor 79
Houston 73
Seattle 57
Cambridge 49
Beijing 46
San Diego 33
Turin 32
Abidjan 24
Ancona 19
Brussels 14
Guangzhou 14
Los Angeles 14
Dallas 13
Izmir 11
London 11
Marche 11
Washington 11
Pune 9
Shanghai 9
Helsinki 8
Redmond 8
Wuhan 8
Jesi 6
Jinhua 6
Milan 6
Monte San Pietrangeli 6
Bologna 5
Falls Church 5
Auburn Hills 4
Kilburn 4
Norwalk 4
Ottawa 4
Southwark 4
Yiwu 4
Belgrade 3
Brisbane 3
Civitanova Marche 3
Foggia 3
Jiaxing 3
Pagani 3
Quanzhou 3
Cairo 2
Gessate 2
Hangzhou 2
Leawood 2
Montréal 2
New Bedfont 2
Nürnberg 2
Paris 2
Porto 2
Prescot 2
Rimini 2
Rome 2
Simi Valley 2
Tolentino 2
Urbino 2
Venice 2
Weihai 2
Wuxi 2
Amsterdam 1
Borås 1
Bray 1
Brescia 1
Camerino 1
Chiaravalle 1
Chiswick 1
Chizhou 1
Dong Ket 1
Edinburgh 1
Fabriano 1
Faridabad 1
Fuzhou 1
Guiyang 1
Hanover 1
Heze 1
Hounslow 1
Iksan 1
Jinan 1
Landshut 1
Laurel 1
Madrid 1
Montreal 1
Munich 1
Nanjing 1
Napoli 1
Totale 3.412
Salva come PNG Salva come JPEG
Nome #
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 120
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 99
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis. 98
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 96
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 92
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 90
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 90
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 88
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 87
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients 86
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 85
Bone formation by distraction clinical and structural studies 84
Pathogenic autoantibodies in systemic sclerosis 82
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 80
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 78
c-MYB transactivates the alpha 2(I) collagen gene. 78
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 78
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 78
Solid monounsaturated diet lowers LDL unsaturation trait and oxidisability in hypercholesterolemic (type IIb) patients 77
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 76
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 76
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 75
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 74
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 73
ALTERATIONS OF ROS PATHWAYS IN SCLERODERMA BEGIN AT STEM CELL LEVEL 73
Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis 73
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 72
Scleroderma fibroblasts constitutively express the long pentraxin PTX3. 69
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: Role of NADPH oxidase and ERK1/2 69
Stimulatory autoantibodies against PDGF receptor in systemic sclerosis 68
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. 68
Agonistic antibodies in systemic sclerosis 68
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 67
Activation in vitro of scleroderma skin fibroblasts is sustained by increased generation of free radicals through the NADPH-oxidase pathway. 66
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. 65
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 64
Metabolomic profile of systemic sclerosis patients 64
Stimulating autoantibodies to PDGF A/B receptor on sera from scleroderma patients 63
Stimulatory Auto-Antibodies To The PDGF Receptor As Pathology Marker And Therapeutic Target 63
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 62
Coenzyme Q homologs and vitamin E in synaptic and non-synaptic occipital cerebral cortex mitochondria in the ageing rat. 61
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 61
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis 61
Development of a Skin-Humanized Model as a Novel Tool to Investigate the Pathogenesis of Scleroderma 60
Tissue-targeted antifibrotic gene therapy using a transgene driven by the promoter of the human type I collagen gene 60
Dietary restriction affects antioxidant levels in rat liver mitochondria diuring aging 59
Stimulatory autoantibodies against PDGF receptors in Scleroderma 58
The Wnt signalling inhibitor gene, WIF-1, expression is downregulated in fibroblasts derived from systemic sclerosis patients by a persistent oxidative stress 58
Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvemen 58
null 58
Dietary restriction affects antioxidant levels in rat liver mitochondria during ageing 57
The long pentraxin PTX3 is a marker of scleroderma fibroblasts activation 56
Coenzyme Q homologs and Vitamin E in synaptic and non-synaptic occipital cerebral cortex mitochondria in the aging rat 56
Biological effects of serum immunoglobulins from scleroderma patients on human pulmonary artery smooth muscle cells. Role of NOX4 and ROS 56
Ha-Ras/ERK1-2 pathway is responsible for oxygen species generation in scleroderma fibroblasts 56
Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality 56
Stimulatory autoantibodies to the PDGF receptor in scleroderma (Correspondence) 55
Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof 54
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes 54
NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis 54
CLONING OF AGONISTIC AUTOANTIBODIES SPECIFIC FOR THE PDGF RECEPTOR FROM THE B CELL REPERTOIRE OF PATIENTSAFFECTED BY SYSTEMIC SCLEROSIS 52
Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of free radical generation through the NADPH oxidase complex pathway 51
Reactive oxygen species are required for manteinance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis. 51
The treatment of UCD200 and scleroderma fibroblasts with siRNAs anti-C-MYB blocks type I collagen transcription: Toward a gene therapy of scleroderma 51
Oxidative stress in scleroderma - Maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway 51
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 51
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 51
Stimulatory auto-antibodies to the PDGF receptor in patients with chronic GVHD. 50
Unbalance between Ha- and Ki-Ras is responsible for scleroderma fibroblast activation 48
The important role of molecular analyses to evaluate the efficacy of Rituximab treatment in a patient affected by severe multineuropathy in mixed cryoglobulinemia disease. 47
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 47
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts 46
Oxidative DNA damage induces the ATM-mediated transcriptional suppressionof the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 46
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 45
New insights into the role of oxidative stress in scleroderma fibrosis. 45
Monounsaturated diet lowers LDL oxidisability in type IIb and type IV dyslipidemia without affecting coenzyme Q10 and vitamin E contents 44
Monounsaturated diet lowers LDL oxidisability in type IIb and type IV dyslipidemia without affecting coenzyme Q10 and vitamin E contents 42
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 42
H-Ras but not K-Ras is responsible for reactive oxygen species generation by scleroderma skin fibroblasts. 41
Restricted immunoglobulin repertoire and evolutionary mechanism of PDGFR-autoreactive memory B cells in systemic sclerosis 39
STIMULATORY AUTOANTIBODIES AGAINST PDGF RECEPTOR IN A LARGE COHORT OF ITALIAN SCLERODERMA PATIENTS 38
Dietary olive oil affects LDL peroxidability in hypercholesterolemic (IIB) patients 38
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 38
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes. 36
Lipid raft colocalization of PDGFR-NADPH complex and receptor integrity are important for the activation of the intracellular signaling by scleroderma IgG in normal human fibroblasts 35
Rituximab for the treatment of cutaneous involvement in systemic sclerosis. evidence for a pathogenetic role of B-CELLS 35
null 35
The Wnt signalling inhibitor gene, WIF1, is silenced in fibroblasts derived from Systemic Sclerosis patients: role of oxidative stress 34
Expression profile and regulation of NOX proteins in Systemic Sclerosis 34
Intracellular free radical production by peripheral blood T lymphocytes from patients with Systemic Sclerosis: role of NADPH oxidase and ras 32
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 32
Restricted immunoglobulin repertoire and evolutionary mechanism of PDGFR-autoreactive memory B cells in systemic sclerosis 32
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 30
null 29
Mechanism of action of agonistic PDGFR auto-antibodies isolated from scleroderma patients 28
Association between TNF-α, cortisol levels, and exposure to PM10 and PM2.5: a pilot study 23
Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study 17
Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine 9
Putative functional pathogenic autoantibodies in systemic sclerosis 6
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 5
Totale 5.768
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020439 0 0 0 0 94 5 93 12 91 5 28 111
2020/2021952 45 108 130 3 111 55 99 44 129 67 120 41
2021/2022614 36 169 9 32 11 24 14 56 42 32 51 138
2022/20231.530 134 188 110 161 138 202 6 98 366 9 82 36
2023/2024752 140 29 40 125 127 170 9 12 0 15 6 79
2024/2025427 153 149 68 14 43 0 0 0 0 0 0 0
Totale 5.770